Corticosteroid inhibits chemokines production in systemic sclerosis patients-Reference-Cited by-同舟云学术

Corticosteroid inhibits chemokines production in systemic sclerosis patients

Published:2017-11 Issue: Volume:127 Page:24-30
ISSN:0039-128X
Container-title:Steroids
language:en
Short-container-title:Steroids

Author:

Dantas Andréa Tavares,de Almeida Anderson Rodrigues,Sampaio Maria Clara Pinheiro Duarte,Cordeiro Marina Ferraz,da Rocha Jr Laurindo Ferreira,de Oliveira Priscilla Stela Santana,Pereira Michelly Cristiny,de Melo Rego Moacyr Jesus Barreto,Marques Claudia Diniz Lopes,da Rocha Pitta Ivan,Duarte Angela Luzia Branco Pinto,da Rocha Pitta Maira Galdino

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Pharmacology,Endocrinology,Molecular Biology,Biochemistry

Reference47 articles.

1. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations;Gourh;Arthritis Res. Ther.,2009

2. Fibrosis and immune dysregulation in systemic sclerosis;Chizzolini;Autoimmun. Rev.,2011

3. Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis;Fenoglio;Clin. Immunol.,2011

4. The role of chemokines in the pathogenesis of scleroderma;Atamas;Curr. Opin. Rheumatol.,2003

5. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement;Scala;Clin. Exp. Immunol.,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Programs Between Steroid-Sensitive and Steroid-Insensitive Interstitial Lung Disease;Inflammation;2023-08-10

2. Chinese Phytopharmacology in dermatology - A Systematic Review;Pharmacological Research - Modern Chinese Medicine;2023-06

3. Cellular and Molecular Diversity in Scleroderma;Seminars in Immunology;2021-12

4. Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients;Inflammopharmacology;2019-05-08

5. Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis;Biochemical Pharmacology;2019-05